Ignite Creation Date:
2024-05-06 @ 6:02 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05517252
Status:
COMPLETED
Last Update Posted:
2023-02-08
First Post:
2022-08-19
Brief Title:
Effect Of Tele-Yoga On Aerobic Capacity Respiratory Muscle Strength And Cognitive Performance In Patients With OSAS
Sponsor:
Uskudar University
Organization:
Uskudar University
Study Overview
Official Title:
Effect Of Tele-Yoga On Aerobic Capacity Respiratory Muscle Strength And Cognitive Performance In Patients With Obstructive Sleep Apnea Syndrome
Status:
COMPLETED
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
OSAS has adverse effects on the functional capacity and quality of life of patients This study aims to examine the impact of yoga on aerobic capacity respiratory muscle strength and cognitive performance in patients with OSAS Patients will be randomly divided into two groups training yoga and control groups The physical and demographic characteristics of the cases who signed the consent form will be recorded Anthropometric measurements circumference measurements respiratory muscle strength MIP and MEP six-minute walking test 6MWT and cardiopulmonary exercise test CPET will be performed Corsi Blocks Touch Test Continuous Performance Test and Stroop Test will be applied to evaluate cognitive performance The Pittsburg Sleep Index will be used for sleep quality the Epworth Sleepiness Scale for sleepiness and the SF-36 scales for health-related quality of life Subjects with OSAS in the yoga group will be included in group-based yoga sessions of 60 minutes 3 times a week for 12 weeks Unilateral basal and apical thoracic expansion exercises will be taught to the patients with OSAS in the control group in the first session They will be followed as a home program At the end of the sixth and twelfth week the evaluations will be made again and the result measurements will be taken
Detailed Description:
Obstructive sleep apnea syndrome OSAS is a syndrome characterized by recurrent upper airway obstructions and accompanying a decrease in oxygen saturation during sleep The prevalence of OSAS is increasing with the aging population and the obesity epidemic OSAS has adverse effects on the functional capacity and quality of life of patients This study aims to examine the effect of yoga on aerobic capacity respiratory muscle strength and cognitive performance in patients with OSAS Patients will be randomly divided into two groups training yoga and control groups The physical and demographic characteristics of the cases who signed the consent form will be recorded Anthropometric measurements circumference measurements respiratory muscle strength MIP and MEP six-minute walking test 6MWT and cardiopulmonary exercise test CPET will be performed Corsi Blocks Touch Test Continuous Performance Test and Stroop Test will be applied to evaluate cognitive performance The Pittsburg Sleep Index will be used for sleep quality the Epworth Sleepiness Scale for sleepiness and the SF-36 scales for health-related quality of life Subjects with OSAS in the yoga group will be included in group-based yoga sessions of 60 minutes 3 times a week for 12 weeks in groups of 4 to 5 participants synchronously in live sessions in an internet-based telerehabilitation environment Yoga sessions will progress according to the protocol determined according to the weeks Unilateral basal and apical thoracic expansion exercises will be taught to the patients with OSAS in the control group in the first session They will be followed as a home program At the end of the sixth and twelfth week the evaluations will be made again and the result measurements will be taken Then the final measurements of the groups will be compared with statistical methods
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None